Health Care: Drugs

Regulus Therapeutics Inc (RGLS: NASDAQ)

$6.54 0.31 | 4.98%
07/29/14 - 04:00 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
RGLSSector Avg.S&P 500
n/a028.94
Price Performance History (% change):
3 Mo1 Yr3 Yr
-9.8408-41.50230
GROWTH12 Mo3 YrCAGR
Revenue54.100
Net Income00
EPS0n/a
Earnings for RGLS:
EBITDA-17.00
REVENUE19.57M
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $-0.22 $-0.23 $-0.93 $-0.77
Number of Analysts 3 3 3 3
High Estimate $-0.17 $-0.17 $-0.65 $-0.70
Low Estimate $-0.28 $-0.28 $-1.14 $-0.84
Prior Year $-0.12 $-0.07 $-0.45 $-0.93
Growth Rate (Year over Year) -80.56% -223.81% -106.67% 17.20%

Portfolios with RGLS

Latest RGLS Headlines from TheStreet

More Financial News for RGLS

Press Releases for RGLS

See All Press Releases

Partner Headlines for RGLS

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter